118 related articles for article (PubMed ID: 26233994)
1. QT Interval Length in Elderly Prostatic Cancer Patients on Anti-Testosterone Treatment.
Lubart E; Yarovoy A; Gal G; Krakover R; Leibovitz A
Isr Med Assoc J; 2015 Jun; 17(6):356-9. PubMed ID: 26233994
[TBL] [Abstract][Full Text] [Related]
2. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Risk Factors of QTc Prolongation in Prostate Cancer Patients Undergoing Brachytherapy.
Saad S; Delouya G; Lambert C; Barkati M; Dariane C; Laskine M; Taussky D
Cancer Invest; 2022 Mar; 40(3):219-227. PubMed ID: 35000504
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of prolonged QT interval in obese hypogonadal males.
Pecori Giraldi F; Manzoni G; Michailidis J; Scacchi M; Stramba-Badiale M; Cavagnini F
Obesity (Silver Spring); 2011 Oct; 19(10):2015-8. PubMed ID: 21350439
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B
Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
[TBL] [Abstract][Full Text] [Related]
6. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
7. QT interval disturbances in elderly residents of long-term care facilities.
Lubart E; Segal R; Megid S; Yarovoy A; Leibovitz A
Isr Med Assoc J; 2012 Apr; 14(4):244-6. PubMed ID: 22675843
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA
Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510
[TBL] [Abstract][Full Text] [Related]
9. Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation.
Vrtovec B; Knezevic I; Poglajen G; Sebestjen M; Okrajsek R; Haddad F
Am J Cardiol; 2013 Mar; 111(6):886-90. PubMed ID: 23273526
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of QT interval prolongation in inflammatory bowel disease.
Pattanshetty DJ; Gajulapalli RD; Anna K; Sappati Biyyani RS
Turk J Gastroenterol; 2016 Mar; 27(2):136-42. PubMed ID: 26853794
[TBL] [Abstract][Full Text] [Related]
11. QTc prolongation in children following congenital cardiac disease surgery.
Punn R; Lamberti JJ; Balise RR; Seslar SP
Cardiol Young; 2011 Aug; 21(4):400-10. PubMed ID: 21362209
[TBL] [Abstract][Full Text] [Related]
12. Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer.
Hasegawa K; Ito H; Kaseno K; Miyazaki S; Shiomi Y; Tama N; Ikeda H; Ishida K; Uzui H; Ohno S; Horie M; Yokoyama O; Tada H
J Am Heart Assoc; 2021 Feb; 10(5):e017267. PubMed ID: 33599136
[TBL] [Abstract][Full Text] [Related]
13. Psychotropic drugs associated with corrected QT interval prolongation.
van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
[TBL] [Abstract][Full Text] [Related]
14. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
Barbey JT; Pezzullo JC; Soignet SL
J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of prolonged QT interval duration in male patients with Cushing's disease.
Pecori Giraldi F; Toja PM; Michailidis G; Metinidou A; De Martin M; Scacchi M; Stramba-Badiale M; Cavagnini F
Exp Clin Endocrinol Diabetes; 2011 Apr; 119(4):221-4. PubMed ID: 21374543
[TBL] [Abstract][Full Text] [Related]
16. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients.
Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F
Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464
[TBL] [Abstract][Full Text] [Related]
17. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P
Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
[TBL] [Abstract][Full Text] [Related]
18. Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification.
Goldenberg I; Mathew J; Moss AJ; McNitt S; Peterson DR; Zareba W; Benhorin J; Zhang L; Vincent GM; Andrews ML; Robinson JL; Morray B
J Am Coll Cardiol; 2006 Sep; 48(5):1047-52. PubMed ID: 16949500
[TBL] [Abstract][Full Text] [Related]
19. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
20. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation.
Patel N; Veve M; Kwon S; McNutt LA; Fish D; Miller CD
HIV Med; 2013 Sep; 14(8):463-71. PubMed ID: 23506263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
